Targeted Radiopharmaceuticals in the US: The Past, the Present & the Future
Preclinical Evaluation of Emerging Radioisotopes: From Copper to Lead
Targets Beyond PSMA: Avoiding the Niche Label
TRP Toxicity: Chelators & Drug Design
Targeted Radiopharmaceutical Applications: Case Studies of a Variety of Indications
Improving the Accessibility of TRPs to Ensure That This is Treatment Available for All
Beta or Alpha Emitters: Rationale, Considerations & Challenges
Combinations: Understanding the Importance, Rationale & Challenges
Clinical Readouts & Emerging Success Stories
What’s Next for The Targeted Radionuclide Therapies in the US: Working Together to Address the Key Roadblocks – Scalability, Supply, Regulation, Reimbursement
